• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-1-抗胰蛋白酶缺乏与支气管扩张症:偶然并存还是真正关联?

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?

机构信息

Department of Clinical Medicine and Surgery, Section of Respiratory Disease, University Federico II, AORN dei Colli-Monaldi Hospital, 80138 Naples, Italy.

University Luigi Vanvitelli, U.O.C. Clinica Pneumologica SUN, AORN dei Colli-Monaldi Hospital, 80138 Naples, Italy.

出版信息

Int J Environ Res Public Health. 2020 Mar 29;17(7):2294. doi: 10.3390/ijerph17072294.

DOI:10.3390/ijerph17072294
PMID:32235324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7178111/
Abstract

Alpha-1-antitrypsin deficiency (AATd) is a hereditary disease, mainly characterized by early onset and the lower lobes' predominant emphysema. Bronchiectasis is characterized by dilatation of the bronchial wall and a clinical syndrome whose features are a cough, sputum production and frequent respiratory exacerbations. In the literature, there are many papers concerning these two clinical entities, but there is still a lot of debate about a possible association between them, in particular about the frequency of their association and causal links. The aim of this short communication is to show the literature reports about the association between AATd and bronchiectasis to establish the state of the art and possible future developments in this research field.

摘要

α-1-抗胰蛋白酶缺乏症(AATd)是一种遗传性疾病,主要表现为早发和下叶为主的肺气肿。支气管扩张症的特征是支气管壁扩张和一种临床综合征,其特征是咳嗽、咳痰和频繁的呼吸恶化。在文献中,有许多关于这两种临床实体的论文,但关于它们之间可能存在的关联,特别是关于它们关联的频率和因果关系,仍存在很多争议。本短通讯的目的是展示关于 AATd 和支气管扩张症之间关联的文献报告,以确定该研究领域的现状和可能的未来发展。

相似文献

1
Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?α-1-抗胰蛋白酶缺乏与支气管扩张症:偶然并存还是真正关联?
Int J Environ Res Public Health. 2020 Mar 29;17(7):2294. doi: 10.3390/ijerph17072294.
2
Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中支气管扩张的患病率及影响
Am J Respir Crit Care Med. 2007 Dec 15;176(12):1215-21. doi: 10.1164/rccm.200703-489OC. Epub 2007 Sep 13.
3
Emphysema and bronchiectasis secondary to alpha-1 antitrypsin deficiency.α-1抗胰蛋白酶缺乏继发的肺气肿和支气管扩张
J Coll Physicians Surg Pak. 2013 Mar;23(3):224-5.
4
Alpha1-antitrypsin deficiency and asthma.α1-抗胰蛋白酶缺乏与哮喘。
Monaldi Arch Chest Dis. 2022 Feb 22;92(4). doi: 10.4081/monaldi.2022.2179.
5
Airway disease in alpha-1 antitrypsin deficiency.α1-抗胰蛋白酶缺乏症中的气道疾病。
COPD. 2013 Mar;10 Suppl 1:68-73. doi: 10.3109/15412555.2013.764404.
6
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.与α-1 抗胰蛋白酶缺乏症相关的疾病负担:系统和结构化文献回顾。
Eur Respir Rev. 2022 Mar 23;31(163). doi: 10.1183/16000617.0262-2021. Print 2022 Mar 31.
7
The national alpha-1 antitrypsin deficiency registry in Poland.波兰全国α-1抗胰蛋白酶缺乏症登记处。
COPD. 2015 May;12 Suppl 1:22-6. doi: 10.3109/15412555.2015.1021915.
8
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.α-1 抗胰蛋白酶缺乏症患者支气管扩张症的患病率:EARCO 的初步报告。
Orphanet J Rare Dis. 2023 Aug 12;18(1):243. doi: 10.1186/s13023-023-02830-2.
9
Treatment of Alpha-1 Antitrypsin Deficiency.α-1抗胰蛋白酶缺乏症的治疗
Semin Respir Crit Care Med. 2015 Aug;36(4):470-7. doi: 10.1055/s-0035-1555608. Epub 2015 Aug 3.
10
Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT.α1抗胰蛋白酶缺乏症:CT评估支气管扩张
Radiology. 1996 Apr;199(1):137-41. doi: 10.1148/radiology.199.1.8633137.

引用本文的文献

1
Unraveling Pneumomediastinum in COVID-19 Patients: Insights from a High-Volume-Center Case-Control Study.解析新冠病毒感染患者的纵隔气肿:来自高容量中心病例对照研究的见解
Diseases. 2024 Oct 3;12(10):242. doi: 10.3390/diseases12100242.
2
Management of comorbidities in difficult and severe asthma.重度和难治性哮喘共病的管理
Breathe (Sheff). 2023 Sep;19(3):230133. doi: 10.1183/20734735.0133-2023. Epub 2023 Nov 14.
3
Etiology of Bronchiectasis in the World: Data from the Published National and International Registries.全球支气管扩张症的病因:来自已发表的国家和国际登记处的数据。
J Clin Med. 2023 Sep 5;12(18):5782. doi: 10.3390/jcm12185782.
4
Synthetic neutrophil extracellular traps dissect bactericidal contribution of NETs under regulation of α-1-antitrypsin.人工中性粒细胞胞外陷阱在 α-1-抗胰蛋白酶调控下剖析 NETs 的杀菌作用。
Sci Adv. 2023 Apr 28;9(17):eadf2445. doi: 10.1126/sciadv.adf2445.
5
Risk factors of pneumothorax and pneumomediastinum in COVID-19: a matched case-control study.新型冠状病毒肺炎并发气胸和纵隔气肿的危险因素:一项病例对照研究。
BMC Infect Dis. 2023 Mar 7;23(1):137. doi: 10.1186/s12879-023-08104-3.
6
COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients.COVID-19 对 α-1-抗胰蛋白酶缺乏症患者的护理实践的影响。
BMC Health Serv Res. 2023 Jan 30;23(1):98. doi: 10.1186/s12913-023-09094-3.
7
Designing Clinical Trials in "Regular" COPD Versus Alpha-1 Antitrypsin Deficiency-Associated COPD: "More Alike Than Unalike?".“普通”慢性阻塞性肺疾病与α-1抗胰蛋白酶缺乏相关慢性阻塞性肺疾病的临床试验设计:“相似多于不同?”
Chronic Obstr Pulm Dis. 2022 Jan 27;9(1):95-102. doi: 10.15326/jcopdf.2021.0261.

本文引用的文献

1
α-Antitrypsin deficiency and chronic respiratory disorders.α-1 抗胰蛋白酶缺乏与慢性呼吸疾病。
Eur Respir Rev. 2020 Feb 12;29(155). doi: 10.1183/16000617.0073-2019. Print 2020 Mar 31.
2
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.与α-1抗胰蛋白酶缺乏症、常见变异型免疫缺陷和原发性纤毛运动障碍相关的支气管扩张症的临床特征——来自美国支气管扩张症研究注册中心的结果
Chronic Obstr Pulm Dis. 2019 Apr 9;6(2):145-153. doi: 10.15326/jcopdf.6.2.2018.0156.
3
British Thoracic Society guideline for bronchiectasis in adults.英国胸科学会成人支气管扩张指南。
BMJ Open Respir Res. 2018 Dec 28;5(1):e000348. doi: 10.1136/bmjresp-2018-000348. eCollection 2018.
4
The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.α1-抗胰蛋白酶对中性粒细胞功能的多方面影响。
Front Pharmacol. 2018 Apr 17;9:341. doi: 10.3389/fphar.2018.00341. eCollection 2018.
5
Association between α-antitrypsin and bronchiectasis in patients with humoral immunodeficiency receiving gammaglobulin infusions.α-抗胰蛋白酶与接受丙种球蛋白输注的体液免疫缺陷患者支气管扩张症的关系。
Ann Allergy Asthma Immunol. 2018 Feb;120(2):200-206. doi: 10.1016/j.anai.2017.11.014.
6
Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli.意大利那不勒斯一种新的罕见α-1抗胰蛋白酶突变的描述:PI*M S-那不勒斯
Ann Thorac Med. 2018 Jan-Mar;13(1):59-61. doi: 10.4103/atm.ATM_234_17.
7
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α-antitrypsin deficiency.欧洲呼吸学会声明:α-1 抗胰蛋白酶缺乏症相关肺部疾病的诊断与治疗。
Eur Respir J. 2017 Nov 30;50(5). doi: 10.1183/13993003.00610-2017. Print 2017 Nov.
8
Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.α1-抗胰蛋白酶通过抑制炎症反应和细胞凋亡减轻大鼠呼吸机所致肺损伤。
Exp Biol Med (Maywood). 2018 Jan;243(1):87-95. doi: 10.1177/1535370217740852. Epub 2017 Nov 2.
9
European Respiratory Society guidelines for the management of adult bronchiectasis.欧洲呼吸学会成人支气管扩张症管理指南。
Eur Respir J. 2017 Sep 9;50(3). doi: 10.1183/13993003.00629-2017. Print 2017 Sep.
10
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis.一种与α-1抗胰蛋白酶缺乏症和支气管扩张相关的新型丝氨酸蛋白酶抑制剂A-1(SERPINA-1)错义突变。
Lung. 2017 Oct;195(5):679-682. doi: 10.1007/s00408-017-0033-2. Epub 2017 Jul 1.